Practice considerations of early aspirin administration following coronary artery bypass surgery

Heart Surgery Forum

Volumn 14, Issue 1, 2011, Pages

  Gukop, Philemon ^a   Kakouros, Nicholaos ^a   Hosseini, Morteza Tavakkoli ^a   Valencia, Oswaldo ^a   Kourliouros, Antonios ^a   Sarsam, Mazin ^a   Chandrasekaran, Venkatachalam ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL PRACTICE; CORONARY ARTERY BYPASS SURGERY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COMORBIDITY; CORONARY ARTERY BYPASS; DRUG TOXICITY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOSIS;

EID: 79952240659     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20101087     Document Type: Article

References (12)

1. Casati V, Gerli C, Franco A, et al. 2001. Activation of coagulation and fi brinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 95:1103-9. (Pubitemid 33043224)
2. Dunning J, Versteegh M, Fabbri A, et al. 2008. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73-92.
3. Eagle KA, Guyton RA, Davidoff R, et al. 2004. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340-437.
4. Fremes SE, Levinton C, Naylor CD, Chen E, Christakis GT, Goldman BS. 1993. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg 7:169-80.
5. Gavaghan TP, Gebski V, Baron DW. 1991. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. Circulation 83:1526-33.
6. Goldman S, Copeland J, Moritz T, et al. 1988. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 77:1324-32.
7. Hata M, Sezai A, Niino T, et al. 2007. What is the optimal management for preventing saphenous vein graft diseases?: early results of intravascular angioscopic assessment. Circ J 71:286-7. (Pubitemid 46182707)
8. Mangano DT. 2002. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309-17. (Pubitemid 35215321)
9. Musleh G, Dunning J. 2003. Does aspirin 6 h after coronary artery bypass grafting optimise graft patency? Interact Cardiovasc Thorac Surg 2:413-5.
10. Senior K. 2009. WHO Surgical Safety Checklist has value worldwide. Lancet Infect Dis 9:211.
11. Shukla N, Angelini GD, Ascione R, Talpahewa S, Capoun R, Jeremy JY. 2003. Nitric oxide donating aspirins: novel drugs for the treatment of saphenous vein graft failure. Ann Thorac Surg 75:1437-42. (Pubitemid 36515217)
12. Stein PD, Schunemann HJ, Dalen JE, et al. 2004. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(suppl):600S-8S.